Soleno Therapeutics, Inc. (NasdaqGM: SLNO)
Health Care · Biotechnology · US
$—
— today · — 1Y
Soleno Therapeutics, Inc. (NasdaqGM: SLNO) operates in the Biotechnology industry within the Health Care sector.
trading between 29.43 and 72.80.
Tweenvest scores Soleno Therapeutics, Inc. across four factors: quality 87/100, value 40/100. Its strongest factor is quality.
SLNO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $285.01M
- P/E
- —
- EPS
- 1.77
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $72.80
- 52-week low
- $29.43
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 115
- Next earnings
- —
About Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. (SLNO) operates as a clinical-stage biopharmaceutical company, specializing in the creation and market introduction of groundbreaking treatments for uncommon illnesses. The cornerstone of its therapeutic pipeline is Diazoxide Choline Controlled-Release, a once-daily oral tablet aimed at addressing Prader-Willi Syndrome, currently progressing through an active Phase III clinical evaluation. Established in 1999, the Redwood City, California-headquartered firm adopted its current name, Soleno Therapeutics, Inc., in May 2017, having previously operated as Capnia, Inc.
- ISIN
- US8342033094
- Founded
- 1999
- Listed since
- Nov 13, 2014
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PhaseRx, Inc.OTCPK: PZRX.Q | $12.00 | $— | — |
| ContraFect CorporationOTCPK: CFRX.Q | $11.00 | $0.00 | — |
| Notable Labs, Ltd.OTCPK: NTBL.Q | $10.00 | $— | — |
| OncoSec Medical IncorporatedOTCPK: ONCS.Q | $6.00 | $0.00 | — |
| Calithera Biosciences, Inc.OTCPK: CALA | $5.00 | $0.00 | -99.00% |
| Biocept, Inc.OTCPK: BIOC.Q | $3.00 | $0.00 | -99.50% |
| Yield10 Bioscience, Inc.OTCPK: YTEN.Q | $1.00 | $— | — |
| LadRx CorporationOTCPK: LADX | $0.00 | $0.00 | -99.50% |
Figures last refreshed Oct 18, 2026.